Intrinsiqq
Larimar Therapeutics Inc. logo

Larimar Therapeutics Inc. Insider Trading

LRMR

Compare
Cluster buy

9 insiders bought 402K of their own stock in 6 days.

Open-market purchases by executives and directors between Nov 11 and Nov 16. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market
+$1.12M
13 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
9 / 0
executives and directors
Last open-market buy
Nov 2026
Nov 16, 2026

Get an email when LRMR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 16
    Russell Clayton
    Chief Medical Officer · bought 3,322 at $3.01
    10K
    4.6% of stake
  • Nov 16
    Jeffrey W Sherman
    Director · bought 3,289 at $3.06
    10K
    66% of stake
  • Nov 12
    Thomas Edward Hamilton
    Director · bought 70,000 at $2.67
    187K
    8.0% of stake
  • Nov 11
    Carole Ben-Maimon
    President and CEO · bought 18,050 at $2.77
    50K
    4.5% of stake
  • Nov 11
    Frank E Thomas
    Director · bought 8,000 at $2.73
    22K
    114% of stake
  • Nov 11
    Joseph Truitt
    Director · bought 3,500 at $2.80
    10K
    127% of stake
  • Nov 11
    John B. Harlow Jr.
    President and COO · bought 17,800 at $2.80
    50K
    36% of stake
  • Nov 11
    Michael Celano
    Chief Financial Officer · bought 18,460 at $2.71
    50K
    8.6% of stake
  • Nov 11
    Gopi Shankar
    Chief Development Officer · bought 5,000 at $2.71
    14K
    6.5% of stake
  • Jul 6
    Thomas Edward Hamilton
    Director · bought 50,000 at $3.34
    167K
    6.1% of stake
  • Feb 27
    Deerfield Mgmt Hif, L.p.
    Large holder · bought 5,000,000 at avg $5.00
    $25M
    16% of stake
  • Feb 27
    Thomas Edward Hamilton
    Director · bought 100,000 at $5.00
    500K
    14% of stake
  • Feb 27
    Frank E Thomas
    Director · bought 5,000 at $5.00
    25K
    250% of stake
  • Feb 27
    Jeffrey W Sherman
    Director · bought 5,000 at $5.00
    25K
    New position
  • Jul 31, 2025
    Deerfield Mgmt Hif, L.p.
    Large holder · bought 9,375,000 at avg $3.20
    $30M
    44% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LRMR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LRMR

CompareIntrinsic value
HCWBHCW Biologics Inc.
$0.75+1.90%15
ALXOAlx Oncology Holdings Inc.
$1.07+4.41%10
PRLDPrelude Therapeutics Incorporated
$3.23-0.77%46
BYSIBeyondSpring Inc.
$0.33-24.49%20
RNTXRein Therapeutics Inc.
$0.37+3.58%10
JAGXJaguar Health, Inc.
$0.22-31.50%40
UNCYUnicycive Therapeutics Inc.
$3.35-5.10%10
COCPCocrystal Pharma Inc.
$0.93-4.11%10

Held by ETFs

LRMR is in 13 US ETFs. The largest of them, with LRMR's weight in each:

Spot a number that looks wrong? Check it in LRMR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing LRMR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.